Equasens Société anonyme (0R9T.L)
EUR 44.15
(1.03%)
EUR 44.15
(1.03%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 50.84 Million EUR | 1049.77% |
| 2022 | -5.35 Million EUR | -112.85% |
| 2021 | 41.64 Million EUR | 36.56% |
| 2020 | 30.49 Million EUR | 10.47% |
| 2019 | 27.6 Million EUR | 160.0% |
| 2018 | 10.61 Million EUR | 142.65% |
| 2017 | -24.89 Million EUR | -45.02% |
| 2016 | -17.16 Million EUR | -38.78% |
| 2015 | -12.37 Million EUR | -13.49% |
| 2014 | -10.9 Million EUR | 19.9% |
| 2013 | -13.6 Million EUR | -77.26% |
| 2012 | -7.67 Million EUR | -29.64% |
| 2011 | -5.92 Million EUR | -2452.59% |
| 2010 | -232 Thousand EUR | 83.53% |
| 2009 | -1.4 Million EUR | -118.08% |
| 2008 | 7.79 Million EUR | -49.83% |
| 2007 | 15.53 Million EUR | 3463.2% |
| 2006 | -462 Thousand EUR | 96.97% |
| 2005 | -15.26 Million EUR | -46.11% |
| 2004 | -10.44 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 26.79 Million EUR | 0.0% |
| 2024 Q1 | 26.79 Million EUR | -47.3% |
| 2023 Q3 | 47.5 Million EUR | -10.92% |
| 2023 FY | 50.84 Million EUR | 1049.77% |
| 2023 Q4 | 50.84 Million EUR | 7.02% |
| 2023 Q1 | 50.52 Million EUR | 1043.81% |
| 2023 Q2 | 53.32 Million EUR | 5.55% |
| 2022 FY | -5.35 Million EUR | -112.85% |
| 2022 Q4 | -5.35 Million EUR | -113.22% |
| 2022 Q3 | 40.48 Million EUR | 78.32% |
| 2022 Q2 | 22.7 Million EUR | -19.13% |
| 2022 Q1 | 28.07 Million EUR | -32.59% |
| 2021 Q3 | 49.24 Million EUR | 80.0% |
| 2021 Q1 | 30.45 Million EUR | -0.15% |
| 2021 Q2 | 27.36 Million EUR | -10.15% |
| 2021 Q4 | 41.64 Million EUR | -15.44% |
| 2021 FY | 41.64 Million EUR | 36.56% |
| 2020 Q4 | 30.49 Million EUR | -20.13% |
| 2020 FY | 30.49 Million EUR | 10.47% |
| 2020 Q2 | 39.02 Million EUR | -11.24% |
| 2020 Q1 | 43.96 Million EUR | 59.25% |
| 2020 Q3 | 38.18 Million EUR | -2.15% |
| 2019 Q3 | 36.11 Million EUR | 239.16% |
| 2019 FY | 27.6 Million EUR | 160.0% |
| 2019 Q4 | 27.6 Million EUR | -23.55% |
| 2019 Q2 | 10.64 Million EUR | -16.19% |
| 2019 Q1 | 12.7 Million EUR | 19.64% |
| 2018 Q3 | 10.61 Million EUR | 498.93% |
| 2018 FY | 10.61 Million EUR | 142.65% |
| 2018 Q2 | 1.77 Million EUR | 5.66% |
| 2018 Q4 | 10.61 Million EUR | -0.01% |
| 2018 Q1 | 1.67 Million EUR | 106.74% |
| 2017 FY | -24.89 Million EUR | -45.02% |
| 2017 Q4 | -24.89 Million EUR | -132.69% |
| 2017 Q3 | -10.69 Million EUR | 40.24% |
| 2017 Q2 | -17.9 Million EUR | 0.0% |
| 2017 Q1 | -17.9 Million EUR | -4.28% |
| 2016 Q4 | -17.16 Million EUR | 0.0% |
| 2016 FY | -17.16 Million EUR | -38.78% |
| 2016 Q1 | -15.63 Million EUR | -26.4% |
| 2016 Q2 | -15.63 Million EUR | 0.01% |
| 2016 Q3 | -17.16 Million EUR | -9.8% |
| 2015 Q1 | -10.45 Million EUR | 4.05% |
| 2015 FY | -12.37 Million EUR | -13.49% |
| 2015 Q2 | -10.45 Million EUR | 0.0% |
| 2015 Q3 | -12.36 Million EUR | -18.25% |
| 2015 Q4 | -12.37 Million EUR | -0.02% |
| 2014 Q3 | -10.9 Million EUR | 21.41% |
| 2014 Q1 | -13.87 Million EUR | -1.93% |
| 2014 Q2 | -13.87 Million EUR | 0.01% |
| 2014 FY | -10.9 Million EUR | 19.9% |
| 2014 Q4 | -10.9 Million EUR | 0.0% |
| 2013 Q2 | -2.8 Million EUR | -0.04% |
| 2013 Q4 | -13.6 Million EUR | -0.01% |
| 2013 Q3 | -13.6 Million EUR | -385.79% |
| 2013 FY | -13.6 Million EUR | -77.26% |
| 2013 Q1 | -2.8 Million EUR | 63.53% |
| 2012 Q4 | -7.67 Million EUR | 0.0% |
| 2012 Q2 | -11.18 Million EUR | 0.0% |
| 2012 FY | -7.67 Million EUR | -29.64% |
| 2011 Q2 | 20.48 Million EUR | 0.0% |
| 2011 Q4 | -5.92 Million EUR | 0.0% |
| 2011 FY | -5.92 Million EUR | -2452.59% |
| 2010 Q2 | 18.49 Million EUR | 0.0% |
| 2010 FY | -232 Thousand EUR | 83.53% |
| 2010 Q4 | -232 Thousand EUR | 0.0% |
| 2009 FY | -1.4 Million EUR | -118.08% |
| 2009 Q4 | -1.4 Million EUR | 0.0% |
| 2008 FY | 7.79 Million EUR | -49.83% |
| 2007 FY | 15.53 Million EUR | 3463.2% |
| 2006 FY | -462 Thousand EUR | 96.97% |
| 2005 FY | -15.26 Million EUR | -46.11% |
| 2004 FY | -10.44 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Cegedim SA | 238.49 Million EUR | 78.683% |
| Guerbet SA | 313.3 Million EUR | 83.773% |
| Nexus AG | 2.81 Million EUR | -1708.645% |
| Bastide Le Confort Médical SA | 333.35 Million EUR | 84.749% |
| Revenio Group Oyj | -2.8 Million EUR | 1915.75% |
| Drägerwerk AG & Co. KGaA | 199.42 Million EUR | 74.506% |
| Sartorius Aktiengesellschaft | 4.89 Billion EUR | 98.962% |
| LNA Santé SA | 810.5 Million EUR | 93.727% |
| Siemens Healthineers AG | -1 Billion EUR | 105.039% |
| Medios AG | -53.89 Million EUR | 194.339% |
| Stratec SE | 107.83 Million EUR | 52.855% |